Full Text View
Tabular View
No Study Results Posted
Related Studies
Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
This study has been completed.
Study NCT00003019   Information provided by National Cancer Institute (NCI)

First Received on August 3, 2000.   Last Updated on November 2, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Desmoid Tumor
Additional conditions recognized in this trial
Fibromatosis, Aggressive
More general conditions related to this trial
Fibroma
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Connective and Soft Tissue
Neoplasms, Connective Tissue
Neoplasms, Fibrous Tissue
Interventions listed in this trial
methotrexate
vinblastine sulfate
Additional drug interventions recognized in this trial
Vinblastine
More general drug interventions related to this trial
Abortifacient Agents
Abortifacient Agents, Nonsteroidal
Antimetabolites
Antimetabolites, Antineoplastic
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Antirheumatic Agents
Dermatologic Agents
Enzyme Inhibitors
Folic Acid Antagonists
Immunologic Factors
Immunosuppressive Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Pediatric Oncology Group
National Cancer Institute (NCI)
Children's Cancer Group


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services